New Delhi: March 04, 2011
The Translational Health Sciences and Technology Institute (THSTI), an autonomous institute of the Indian government's Department of Biotechnology, and the International AIDS Vaccine Initiative (IAVI) has announced an agreement to jointly establish, operate and fund an HIV Vaccine Design Program in India. The program will include the establishment of a new laboratory on the campus of THSTI in New Delhi. The program will primarily focus on one of the greatest scientific challenges of AIDS vaccine design and development: the elicitation of antibodies capable of neutralizing a broad spectrum of circulating HIV variants, a problem that stems in large part from the almost unparalleled mutability of HIV.
Read more
The Translational Health Sciences and Technology Institute (THSTI), an autonomous institute of the Indian government's Department of Biotechnology, and the International AIDS Vaccine Initiative (IAVI) has announced an agreement to jointly establish, operate and fund an HIV Vaccine Design Program in India. The program will include the establishment of a new laboratory on the campus of THSTI in New Delhi. The program will primarily focus on one of the greatest scientific challenges of AIDS vaccine design and development: the elicitation of antibodies capable of neutralizing a broad spectrum of circulating HIV variants, a problem that stems in large part from the almost unparalleled mutability of HIV.
Read more
RSS Feed
